Cholangitis: Clinical Trials

17 trials for Cholangitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 completed. 17 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 117Completed 17
Phase 22Completed 2

Follow Cholangitis: new trials by email Literature Review of Cholangitis trials Research Report on Cholangitis

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CS0159
CS0159 - Primary Sclerosing Cholangitis (PSC)
Phase 1CompletedCascade Pharmaceuticals, Inc792021-10-262022-10-18
Subcutaneous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanisms in Healthy Male Subjects
CM-101, Placebo - Nonalcoholic Steatohepatitis (NASH), Primary Sclerosing Cholangitis (PSC)
Phase 1CompletedChemomAb Ltd.82019-03-052023-09-14
A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis (PSC)
Curcumin - Primary Sclerosing Cholangitis
Phase 1 / Phase 2CompletedJohn E. Eaton152017-06-092020-01-18
A Study of HTD1801 in Healthy Subjects
HTD1801 - Primary Sclerosing Cholangitis
Phase 1CompletedHighTide Therapeutics (Hong Kong) Limited322017-03-242026-08-11
Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic Function
Cilofexor - Nonalcoholic Steatohepatitis (NASH), Primary Sclerosing Cholangitis (PSC)
Phase 1CompletedGilead Sciences572016-07-132021-01-07
Fecal Microbiota Transplantation for the Treatment of Primary Sclerosing Cholangitis.
Fecal Microbiota Transplantation - Sclerosing Cholangitis
Phase 1 / Phase 2CompletedBrigham and Women's Hospital102016-02-012019-08-28
A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis
Vancomycin - Primary Sclerosing Cholangitis, Inflammatory Bowel Disease
Phase 1CompletedUniversity of Minnesota82015-07-012020-07-17
Biliary Excretion of Conjugated Bile Acids in Humans Measured by 11C-cholylsarcosine PET/CT
11C-CSar, ICG - Cholestasis, Primary Sclerosing Cholangitis
Phase 1CompletedUniversity of Aarhus222013-06-012015-02-23
A Pilot Study of Xifaxan to Treat Patients With PSC
Xifaxan - Primary Sclerosing Cholangitis (PSC)
Phase 1CompletedMayo Clinic162012-08-012014-10-15
Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis
Oral all-trans retinoic acid (ATRA) - Cholangitis, Sclerosing
Phase 1CompletedYale University192011-10-012016-07-14
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
ursodeoxycholic acid (UDCA) - Primary Sclerosing Cholangitis
Phase 1CompletedUniversity of Tennessee272010-10-012017-10-26
A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis
Vancomycin, Metronidazole - Primary Sclerosing Cholangitis
Phase 1CompletedMayo Clinic352010-02-012013-09-19
Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC)
Erlotinib (Tarceva) - Primary Sclerosing Cholangitis, Trisomy 7
Phase 1CompletedMayo Clinic62009-08-012014-01-10
Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
Vancomycin - Primary Sclerosing Cholangitis, Biliary Atresia
Phase 1CompletedStanford University322007-05-012016-05-18
Evaluation of DHA for the Treatment of PSC
Docosahexaenoic Acid (DHA) - Primary Sclerosing Cholangitis, Colitis
Phase 1CompletedBeth Israel Deaconess Medical Center102005-12-012015-03-11
Minocycline in Primary Sclerosing Cholangitis (PSC)
Minocycline - Primary Sclerosing Cholangitis
Phase 1CompletedMayo Clinic162003-02-012010-12-07
Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis
budesonide - Cholangitis, Sclerosing, Liver Cirrhosis, Biliary
Phase 1CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)221997-05-012017-05-31

Narrower conditions

Cholangitis, Sclerosing (17)  ·  Fibrosis (2)  ·  Liver Cirrhosis, Biliary (2)  ·  Non-alcoholic Fatty Liver Disease (2)  ·  Biliary Atresia (1)  ·  Cholangiocarcinoma (1)  ·  Cholestasis (1)  ·  Colitis (1)  ·  Gastrointestinal Diseases (1)  ·  Hepatitis, Autoimmune (1)  ·  Inflammatory Bowel Diseases (1)  ·  Rare Diseases (1)  ·  Scleroderma, Systemic (1)

Broader conditions

Bile Duct Diseases (17)  ·  Biliary Tract Diseases (17)  ·  Digestive System Diseases (17)  ·  Liver Diseases (5)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Cholestasis, Intrahepatic (2)  ·  Fatty Liver (2)  ·  Gastroenteritis (2)  ·  Gastrointestinal Diseases (2)  ·  Intestinal Diseases (2)  ·  Liver Cirrhosis (2)  ·  Adenocarcinoma (1)  ·  Autoimmune Diseases (1)

Interventions

Vancomycin (3)  ·  Budesonide (1)  ·  Curcumin (1)  ·  Docosahexaenoic Acids (1)  ·  Erlotinib Hydrochloride (1)  ·  Fecal Microbiota Transplantation (1)  ·  Fish Oils (1)  ·  Indocyanine Green (1)  ·  Metronidazole (1)  ·  Minocycline (1)  ·  Rifaximin (1)  ·  Tretinoin (1)  ·  Ursodeoxycholic Acid (1)  ·  cholylsarcosine (1)  ·  cilofexor (1)

Sponsors

Mayo Clinic (4)  ·  Beth Israel Deaconess Medical Center (1)  ·  Brigham and Women's Hospital (1)  ·  Cascade Pharmaceuticals, Inc (1)  ·  ChemomAb Ltd. (1)  ·  Gilead Sciences (1)  ·  HighTide Therapeutics (Hong Kong) Limited (1)  ·  John E. Eaton (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  Stanford University (1)  ·  University of Aarhus (1)  ·  University of Minnesota (1)  ·  University of Tennessee (1)  ·  Yale University (1)

Countries

United States (13)  ·  Australia (1)  ·  Denmark (1)  ·  Israel (1)  ·  New Zealand (1)

Top investigators

Arnon Aharon, MD (1)  ·  Benjamin Shneider, M.D. (1)  ·  Byron P Vaughn, MD (1)  ·  Dennis D Black, M.D. (1)  ·  James L Boyer, MD (1)  ·  Janet Wong, Doctor (1)  ·  Jayant A Talwalkar, MD (1)  ·  Jayant Talwalkar, MD (1)  ·  Joshua Korzenik, MD (1)  ·  Kathleen Doisy, MD (1)  ·  Keith D. Lindor (1)  ·  Keith D. Lindor, M.D. (1)  ·  Kenneth L Cox, MD (1)  ·  Nicholas F LaRusso, M.D. (1)

Results publications

PMID 10655252, PMID 23054338, PMID 23384404, PMID 24914504, PMID 28249726, PMID 32633158, PMID 42271063

NIH funding

R03DK052344 (1), R03DK071851 (1)